Additionally, NLRP3 inhibitors have the potential to be effective in treating other inflammatory and autoimmune disorders such as gout, Alzheimer’s disease, and certain cancers, which makes the development of NLRP3 inhibitors a promising area of research [118,119,120,121]. This evidence concerns the gene NLRP3 and autoimmune disease.